Cascadia Drug Development Group

Cascadia Drug Development Group is a specialized drug development consultancy focused on immunology, biologics, and small molecules. It offers end-to-end strategic and operational support, from target validation and indication selection to preclinical development and regulatory planning, primarily for biotech clients and investors. Founded by seasoned industry veterans, the firm utilizes a virtual, asset-light model to provide high-quality, cost-effective expertise, positioning itself as a single point of contact for complex therapeutic development challenges.

Integrated drug development service model and curated network of external experts providing coordinated support across strategy, preclinical development, and regulatory planning, with a focus on immunology.

Competes with large, full-service Contract Research Organizations (CROs) and a wide array of boutique life science consulting firms. Differentiation is based on deep, hands-on immunology expertise, an integrated project coordination model, and the seniority of its founding team with direct experience advancing programs to the clinic.